Mogamulizumab-Induced Alopecia: Multicentric Case Series - Clinical, Trichoscopic, and Histological Characterization

    R Rodriguez, Daniel Falkenhain‐López, Pablo L. Ortiz‐Romero, José Buendía, Carlos J. Calvo Asín, José Luis Rodríguez‐­Peralto, Irene Navarro, Alba Guglielmo, Alessandro Pileri, Michela Starace, David Saceda Corralo, Virginia Velasco‐Tamariz
    Studysummary In this study, researchers found that mogamulizumab-associated rashes and alopecia are common in patients treated for mycosis fungoides and Sézary syndrome and may be linked with a good treatment response.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results